The relationship between RSV bronchiolitis and recurrent wheeze: The chicken and the egg

Early Human Development

Volumn 87, Issue SUPPL., 2011, Pages

  Bont, L ^a   Ramilo, O ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY CONDUCTANCE; ARTICLE; CARDIOVASCULAR RISK; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; LUNG DISEASE; MORBIDITY; PATHOGENESIS; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL BRONCHIOLITIS; WHEEZING;

ANIMALS; BRONCHIOLITIS; CHICKENS; DISEASE SUSCEPTIBILITY; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; METAPHOR; OVUM; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 79951814387     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.01.011     Document Type: Article

References (45)

1. Smyth R.L., Openshaw P.J. Bronchiolitis. Lancet 2006, 368(9532):312-322.
2. Broughton L.S., Bhat R., Roberts A., Zuckerman M., Rafferty G., Greenough A. Diminished lung function, RSV infection and respiratory morbidity in prematurely born infants. Arch Dis Child 2006, 91:26-30.
3. Tregoning J.S., Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010, 23(1):74-98.
4. Rooney J.C., Williams H.E. The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr 1971, 79(5):744-747.
5. Perez-Yarza E.G., Moreno A., Lazaro P., Mejias A., Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr Infect Dis J 2007, 26(8):733-739.
6. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161(5):1501-1507.
7. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005, 171(2):137-141.
8. Sigurs N., Aljassim F., Kjellman B., Robinson P.D., Sigurbergsson F., Bjarnason R. Asthma and allergy patterns over 18years after severe RSV bronchiolitis in the first year of life. Thorax 2010, 65:1045-1052.
9. Korppi M., Piippo-Savolainen E., Korhonen K., Remes S. Respiratory morbidity 20years after RSV infection in infancy. Pediatr Pulmonol 2004, 38(2):155-160.
10. Henderson J., Hilliard T.N., Sherriff A., Stalker D., Al S.N., Thomas H.M. Hospitalization for RSV bronchiolitis before 12months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005, 16(5):386-392.
11. Bont L., van Aalderen W.M., Versteegh J., Brus F., Draaisma J.T., Pekelharing-Berghuis M. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing. Pediatr Infect Dis J 2001, 20(3):277-282.
12. Bont L., Steijn M., van Aalderen W.M., Kimpen J.L. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life. Pediatr Infect Dis J 2004, 23(5):414-417.
13. Thomsen S.F., Stensballe L.G., Skytthe A., Kyvik K.O., Backer V., Bisgaard H. Increased concordance of severe respiratory syncytial virus infection in identical twins. Pediatrics 2008, 121(3):493-496.
14. Choi E.H., Lee H.J., Yoo T., Chanock S.J. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002, 186(9):1207-1211.
15. Janssen R., Bont L., Siezen C.L., Hodemaekers H.M., Ermers M.J., Doornbos G. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 2007, 196(6):826-834.
16. Forton J.T., Rowlands K., Rockett K., Hanchard N., Herbert M., Kwiatkowski D.P. Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax 2009, 64(4):345-352.
17. Siezen C.L., Bont L., Hodemaekers H.M., Ermers M.J., Doornbos G., Van't Slot R. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr Infect Dis J 2009, 28(4):333-335.
18. Miyairi I., DeVincenzo J.P. Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 2008, 21(4):686-703.
19. Tal G., Mandelberg A., Dalal I., Cesar K., Somekh E., Tal A. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004, 189(11):2057-2063.
20. Puthothu B., Forster J., Heinzmann A., Krueger M. TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis Markers 2006, 22(5-6):303-308.
21. Awomoyi A.A., Rallabhandi P., Pollin T.I., Lorenz E., Sztein M.B., Boukhvalova M.S. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 2007, 179(5):3171-3177.
22. Lofgren J., Marttila R., Renko M., Ramet M., Hallman M. Toll-like receptor 4 Asp299Gly polymorphism in respiratory syncytial virus epidemics. Pediatr Pulmonol 2010, 45(7):687-692.
23. Hoebee B., Rietveld E., Bont L., Oosten M., Hodemaekers H.M., Nagelkerke N.J. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 2003, 187(1):2-11.
24. Puthothu B., Krueger M., Forster J., Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 2006, 193(3):438-441.
25. Broughton S., Bhat R., Roberts A., Zuckerman M., Rafferty G., Greenough A. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch Dis Child 2006, 91(1):26-30.
26. Friedrich L., Pitrez P.M., Stein R.T., Goldani M., Tepper R., Jones M.H. Growth rate of lung function in healthy preterm infants. Am J Respir Crit Care Med 2007, 176(12):1269-1273.
27. Fauroux B. Special populations. Paediatr Respir Rev 2009, 10(Suppl 1):21-22.
28. van Ewijk B.E., Wolfs T.F., Aerts P.C., Van Kessel K.P., Fleer A., Kimpen J.L. RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 2007, 61(4):398-403.
29. de Vrankrijker A.M., Wolfs T.F., Ciofu O., Høiby N., van der Ent C.K., Poulsen S.S. Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice. J Med Virol 2009, 81(12):2096-2103.
30. Martinez F.D., Morgan W.J., Wright A.L., Holberg C.J., Taussig L.M. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988, 319:1112-1117.
31. van der Zalm M.M., Uiterwaal C.S., Wilbrink B., Koopman M., Verheij T.J., Van der Ent C.K. The influence of neonatal lung function on rhinovirus associated wheeze. Am J Respir Crit Care Med 2010, 183:262-267.
32. Bloemers B.L., van Furth A.M., Weijerman M.E., Gemke R.J., Broers C.J., Kimpen J.L. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis-a prospective birth-cohort study. Pediatrics 2007, 120(4):e1076-e1081.
33. Shah P.S., Hellmann J., Adatia I. Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn. J Perinat Med 2004, 32(2):168-170.
34. Uong E.C., McDonough J.M., Tayag-Kier C.E., Zhao H., Haselgrove J. Magnetic resonance imaging of the upper airway in children with Down syndrome. Am J Respir Crit Care Med 2001, 163(3 Pt 1):731-736.
35. Bloemers B.L., Broers C.J., Bont L., Weijerman M.E., Gemke R.J., van Furth A.M. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect 2010, 12(11):799-808.
36. Bont L., Kimpen J.L. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive Care Med 2002, 28(5):616-621.
37. Wilson C.B. Immunological basis for increased susceptibility of the neonate to infection. J Pediatr 1986, 108:1-12.
38. Copenhaver C.C., Gern J.E., Li Z., Shult P.A., Rosenthal L.A., Mikus L.D. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 2004, 170(2):175-180.
39. Belderbos M.E., van Bleek G.M., Levy O., Blanken M.O., Houben M.L., Schuijff L. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009, 133(2):228-237.
40. Fjaerli H.O., Bukholm G., Skjaeret C., Holden M., Nakstad B. Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis 2007, 196(3):394-404.
41. Jafri H.S., Chavez-Bueno S., Mejias A., Gomez A.M., Rios A.M., Nassi S.S.. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 2004, 189(10):1856-1865.
42. Mejias A., Chavez-Bueno S., Rios A.M., Aten M.F., Raynor B., Peromingo E. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency. Antimicrob Agents Chemother 2005, 49(11):4700-4707.
43. Estripeaut D., Torres J.P., Somers C.S., Tagliabue C., Khokhar S., Bhoj V.G. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 2008, 198(10):1435-1443.
44. Mejias A., Chavez-Bueno S., Rios A.M., Saavedra-Lozano J., Fonseca Aten M., Hatfield J. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother 2004, 48(5):1811-1822.
45. Simoes E.A., Groothuis J.R., Carbonell-Estrany X., Rieger C.H., Mitchell I., Fredrick L.M. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr 2007, 151(1):34-42. 42.